Literature DB >> 9536958

Conclusive evidence of endotoxaemia in biliary obstruction.

W D Clements1, P Erwin, M D McCaigue, I Halliday, G R Barclay, B J Rowlands.   

Abstract

BACKGROUND: Endotoxaemia is implicated in the pathophysiology of obstructive jaundice. The EndoCab enzyme linked immunosorbent assay (ELISA) is a novel assay which measures endogenous antibody (IgG) to the inner core region of circulating endotoxins (ACGA). AIMS: To investigate the significance of endotoxaemia in biliary obstruction using the EndoCab assay and assess the specificity of the humoral response to endotoxin compared with an exogenous antigenic challenge (tetanus toxoid, TT).
METHODS: Three groups of adult male Wistar rats were studied: no operation, sham operation, and bile duct ligation for 21 days (BDL). In the second study, rats rats received prior immunisation with TT.
RESULTS: In the preliminary experiment, plasma ACGA was significantly increased in the BDL group (306.6 (18.3)% versus 119.9 (6.7)% and 105.2 (4.6)% in the sham and no operation groups, respectively; p < 0.001). Although the mean endotoxin concentration in the BDL group was greater than that in the control groups this was not significant. There was a strong positive correlation between ACGA and endotoxin concentrations (p = 0.0021). In the second study mean ACGA after 21 days of BDL was significantly elevated (267.1 (31.2)% versus 101.6 (21.2)% at baseline, p < 0.0001). ACGA was unaffected in the other two groups. TT antibody concentrations fell in all three groups; only in the BDL group was the fall significant (97.6 (5.3)% versus 78.8 (4.2)% at baseline, p < 0.05).
CONCLUSIONS: The specific rise in ACGA supports the hypothesis that endotoxin has an integral role in the pathophysiology of obstructive jaundice. The production of anticore glycolipid antibodies specifically reflects systemic endotoxaemia in this model. The EndoCab assay provides a novel, sensitive, and specific method for endotoxin detection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9536958      PMCID: PMC1726981          DOI: 10.1136/gut.42.2.293

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  55 in total

1.  Surgical morbidity and mortality in one hundred and twenty-nine patients with obstructive jaundice.

Authors:  J D Greig; Z H Krukowski; N A Matheson
Journal:  Br J Surg       Date:  1988-03       Impact factor: 6.939

2.  The inactivation of endotoxin after interaction with certain proteins of normal serum.

Authors:  R C Skarnes
Journal:  Ann N Y Acad Sci       Date:  1966-06-30       Impact factor: 5.691

3.  Effect of bile acids on the intestinal absorption of endotoxin in rats.

Authors:  L T Kocsár; L Bertók; V Várterész
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

Review 4.  Inflammatory and immunologic effects of obstructive jaundice: pathogenesis and treatment.

Authors:  A N Kimmings; S J van Deventer; H Obertop; E A Rauws; D J Gouma
Journal:  J Am Coll Surg       Date:  1995-12       Impact factor: 6.113

5.  Prediction of risk in biliary surgery.

Authors:  S L Blamey; K C Fearon; W H Gilmour; D H Osborne; D C Carter
Journal:  Br J Surg       Date:  1983-09       Impact factor: 6.939

6.  The role of endotoxin immunity, neutrophil degranulation and contact activation in the pathogenesis of post-operative organ dysfunction.

Authors:  M G Mythen; G R Barclay; G Purdy; C Hamilton-Davies; I J Mackie; A R Webb; S J Machin
Journal:  Blood Coagul Fibrinolysis       Date:  1993-12       Impact factor: 1.276

7.  Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins.

Authors:  S Iwanaga; T Morita; T Harada; S Nakamura; M Niwa; K Takada; T Kimura; S Sakakibara
Journal:  Haemostasis       Date:  1978

8.  Factors affecting mortality in biliary tract surgery.

Authors:  H A Pitt; J L Cameron; R G Postier; T R Gadacz
Journal:  Am J Surg       Date:  1981-01       Impact factor: 2.565

9.  The complications of pancreatectomy.

Authors:  M Trede; G Schwall
Journal:  Ann Surg       Date:  1988-01       Impact factor: 12.969

10.  Endotoxemia and cholestasis.

Authors:  P T Roughneen; S C Kumar; N R Pellis; B J Rowlands
Journal:  Surg Gynecol Obstet       Date:  1988-09
View more
  16 in total

1.  Immunomodulation in surgical practice.

Authors:  R Andersson; B Andersson; E Andersson; G Eckerwall; M Nordén; B Tingstedt
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 2.  Pathophysiology of increased intestinal permeability in obstructive jaundice.

Authors:  Stelios F Assimakopoulos; Chrisoula D Scopa; Constantine E Vagianos
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

3.  Perioperative outcome of Whipple's procedure with special attention to the impact of preoperative biliary drainage: a real-life scenario.

Authors:  Sukanta Ray; Somak Das; Tuhin Subhra Mandal; Koustav Jana; Roby Das; Dilip Kumar; Zuber Ansari; Sujan Khamrui
Journal:  Updates Surg       Date:  2021-04-03

4.  Effects of dexamethasone on small bowel and kidney oxidative stress and histological alterations in bile duct-ligated rats.

Authors:  Hayrettin Ozturk; Halil Eken; Hulya Ozturk; Huseyin Buyukbayram
Journal:  Pediatr Surg Int       Date:  2006-08-01       Impact factor: 1.827

Review 5.  Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives.

Authors:  Juan P Arab; Marco Arrese; Vijay H Shah
Journal:  Hepatol Res       Date:  2020-01-13       Impact factor: 4.288

6.  Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.

Authors:  Juan P Arab; Rosa M Martin-Mateos; Vijay H Shah
Journal:  Hepatol Int       Date:  2017-05-26       Impact factor: 6.047

7.  Protective effect and mechanisms of radix astragali injection on the intestinal mucosa of rats with obstructive jaundice.

Authors:  Zhang Xiping; Weng Ke; Yu Yaping; Zhao Hongchan; Cheng Qihui
Journal:  Mediators Inflamm       Date:  2010-03-14       Impact factor: 4.711

8.  Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats.

Authors:  A Giacometti; O Cirioni; R Ghiselli; F Mocchegiani; G D'Amato; M Simona Del Prete; F Orlando; W Kamysz; J Lukasiak; V Saba; G Scalise
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

9.  Biliary obstruction reduces hepatic killing and phagocytic clearance of circulating microorganisms in rats.

Authors:  Sumito Hoshino; Zhaoli Sun; Keiichiro Uchikura; Kyoji Tsugane; Eugene Ceppa; Gregory B Bulkley; Andrew S Klein
Journal:  J Gastrointest Surg       Date:  2003 May-Jun       Impact factor: 3.452

10.  Bile duct ligation in rats: a reliable model of hepatorenal syndrome?

Authors:  Stelios F Assimakopoulos; Constantine E Vagianos
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.